Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,287 full-time employees. The firm is engaged in the manufacture and sale of prescription and over-the-counter drugs. The firm has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Ono Pharmaceutical Co Ltd có cổ tức hàng năm là 0.56 mỗi cổ phiếu, với tỷ suất là 0.00%. Cổ tức được trả nửa năm và ngày ex-dividend cuối cùng là Sep 29, 2025.